Literature DB >> 18755824

Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.

Rj Mills1, Ca Young, Rs Nicholas, Jf Pallant, A Tennant.   

Abstract

BACKGROUND: The 9-item, Fatigue Severity Scale (FSS-9) has been widely used as an outcome measure in multiple sclerosis (MS). Modern psychometric theory, in the form of the Rasch measurement model, has set new quality standards for outcome measures by appraising a broad range of measurement properties in addition to the reliability and validity emphasized by classical test theory.
OBJECTIVE: To appraise the FSS-9 by application of the Rasch model.
METHOD: The FSS-9 was posted to patients with clinically definite MS in two centers in the United Kingdom. Analysis was based on 416 records (55% response).
RESULTS: The 9-item scale failed to meet Rasch model expectations. Two items had poor discrimination across the scale, and two further items showed bias for factors such as age. Removal of these four items provided a valid 5-item Rasch scale that satisfied strict tests of unidimensionality.
CONCLUSION: Summating the nine items of the FSS-9 is invalid. Five items (FSS-5), which seem to be measuring the social impact of fatigue, provide a strictly unidimensional Rasch scale. Studies using the FSS-9 may need to be re-evaluated using the FSS-5, preferably using the Rasch transformed scores.

Entities:  

Mesh:

Year:  2008        PMID: 18755824     DOI: 10.1177/1352458508096215

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  32 in total

1.  Comparison of the psychometric properties of two fatigue scales in multiple sclerosis.

Authors:  Dagmar Amtmann; Alyssa M Bamer; Vanessa Noonan; Nina Lang; Jiseon Kim; Karon F Cook
Journal:  Rehabil Psychol       Date:  2012-05

2.  A 7-item version of the fatigue severity scale has better psychometric properties among HIV-infected adults: an application of a Rasch model.

Authors:  Anners Lerdal; Anders Kottorp; Caryl Gay; Bradley E Aouizerat; Carmen J Portillo; Kathryn A Lee
Journal:  Qual Life Res       Date:  2011-03-10       Impact factor: 4.147

3.  Group cognitive rehabilitation to reduce the psychological impact of multiple sclerosis on quality of life: the CRAMMS RCT.

Authors:  Nadina B Lincoln; Lucy E Bradshaw; Cris S Constantinescu; Florence Day; Avril Er Drummond; Deborah Fitzsimmons; Shaun Harris; Alan A Montgomery; Roshan das Nair
Journal:  Health Technol Assess       Date:  2020-01       Impact factor: 4.014

4.  Associations of sense of coherence with psychological distress and quality of life in inflammatory bowel disease.

Authors:  Thiago H Freitas; Elias Andreoulakis; Gilberto S Alves; Hesley L L Miranda; Lúcia L B C Braga; Thomas Hyphantis; André F Carvalho
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach.

Authors:  Giovanni Iolascon; Michele Vitacca; Elena Carraro; Carmelo Chisari; Pietro Fiore; Sonia Messina; Tiziana Mongini; Antimo Moretti; Valeria A Sansone; Antonio Toscano; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2019-12-07       Impact factor: 3.307

6.  Ecological Momentary Assessment of Pain, Fatigue, Depressive, and Cognitive Symptoms Reveals Significant Daily Variability in Multiple Sclerosis.

Authors:  Anna L Kratz; Susan L Murphy; Tiffany J Braley
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

7.  Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale.

Authors:  Ulla Werlauff; A Højberg; R Firla-Holme; B F Steffensen; J Vissing
Journal:  Qual Life Res       Date:  2013-11-09       Impact factor: 4.147

8.  Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS).

Authors:  Roger J Mills; Carolyn A Young; Julie F Pallant; Alan Tennant
Journal:  Health Qual Life Outcomes       Date:  2010-02-12       Impact factor: 3.186

9.  Interpretation of response categories in patient-reported rating scales: a controlled study among people with Parkinson's disease.

Authors:  Ida Knutsson; Helena Rydström; Jan Reimer; Per Nyberg; Peter Hagell
Journal:  Health Qual Life Outcomes       Date:  2010-06-24       Impact factor: 3.186

10.  Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands.

Authors:  Arthur Derksen; Lidwine B Mokkink; Marc B Rietberg; Dirk L Knol; Raymond W J G Ostelo; Bernard M J Uitdehaag
Journal:  Qual Life Res       Date:  2013-02-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.